Redjuvenate Medical Ltd - Accounts to registrar (filleted) - small 23.2.5

Redjuvenate Medical Ltd - Accounts to registrar (filleted) - small 23.2.5


IRIS Accounts Production v24.1.0.578 12888072 Board of Directors Board of Directors 1.10.22 30.9.23 30.9.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh128880722022-09-30128880722023-09-30128880722022-10-012023-09-30128880722021-09-30128880722021-10-012022-09-30128880722022-09-3012888072ns15:EnglandWales2022-10-012023-09-3012888072ns14:PoundSterling2022-10-012023-09-3012888072ns10:Director12022-10-012023-09-3012888072ns10:Director22022-10-012023-09-3012888072ns10:PrivateLimitedCompanyLtd2022-10-012023-09-3012888072ns10:SmallEntities2022-10-012023-09-3012888072ns10:AuditExempt-NoAccountantsReport2022-10-012023-09-3012888072ns10:SmallCompaniesRegimeForDirectorsReport2022-10-012023-09-3012888072ns10:SmallCompaniesRegimeForAccounts2022-10-012023-09-3012888072ns10:FullAccounts2022-10-012023-09-3012888072ns10:OrdinaryShareClass12022-10-012023-09-3012888072ns10:RegisteredOffice2022-10-012023-09-3012888072ns5:CurrentFinancialInstruments2023-09-3012888072ns5:CurrentFinancialInstruments2022-09-3012888072ns5:Non-currentFinancialInstruments2023-09-3012888072ns5:Non-currentFinancialInstruments2022-09-3012888072ns5:ShareCapital2023-09-3012888072ns5:ShareCapital2022-09-3012888072ns5:RetainedEarningsAccumulatedLosses2023-09-3012888072ns5:RetainedEarningsAccumulatedLosses2022-09-3012888072ns5:LeaseholdImprovements2022-10-012023-09-3012888072ns5:PlantMachinery2022-10-012023-09-3012888072ns5:FurnitureFittings2022-10-012023-09-3012888072ns5:ComputerEquipment2022-10-012023-09-3012888072ns5:LeaseholdImprovements2022-09-3012888072ns5:PlantMachinery2022-09-3012888072ns5:FurnitureFittings2022-09-3012888072ns5:ComputerEquipment2022-09-3012888072ns5:LeaseholdImprovements2023-09-3012888072ns5:PlantMachinery2023-09-3012888072ns5:FurnitureFittings2023-09-3012888072ns5:ComputerEquipment2023-09-3012888072ns5:LeaseholdImprovements2022-09-3012888072ns5:PlantMachinery2022-09-3012888072ns5:FurnitureFittings2022-09-3012888072ns5:ComputerEquipment2022-09-3012888072ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-09-3012888072ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-09-3012888072ns10:OrdinaryShareClass12023-09-30
REGISTERED NUMBER: 12888072 (England and Wales)




















Financial Statements

for the Year Ended 30 September 2023

for

REDJUVENATE MEDICAL LTD

REDJUVENATE MEDICAL LTD (REGISTERED NUMBER: 12888072)






Contents of the Financial Statements
for the Year Ended 30 September 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


REDJUVENATE MEDICAL LTD

Company Information
for the Year Ended 30 September 2023







DIRECTORS: Dr A D Greenland
Dr Q Xu





REGISTERED OFFICE: 143 Station Road
Hampton
Middlesex
TW12 2AL





REGISTERED NUMBER: 12888072 (England and Wales)





ACCOUNTANTS: Alvis & Company (Accountants) Limited
143 Station Road
Hampton
Middlesex
TW12 2AL

REDJUVENATE MEDICAL LTD (REGISTERED NUMBER: 12888072)

Balance Sheet
30 September 2023

30.9.23 30.9.22
Notes £    £   
FIXED ASSETS
Tangible assets 4 53,280 81,055

CURRENT ASSETS
Debtors 5 385 110
Cash at bank 1,824 3,792
2,209 3,902
CREDITORS
Amounts falling due within one year 6 (227,588 ) (176,393 )
NET CURRENT LIABILITIES (225,379 ) (172,491 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(172,099

)

(91,436

)

CREDITORS
Amounts falling due after more than one
year

7

(15,400

)

(34,338

)

PROVISIONS FOR LIABILITIES (10,123 ) (15,400 )
NET LIABILITIES (197,622 ) (141,174 )

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings (197,722 ) (141,274 )
SHAREHOLDERS' FUNDS (197,622 ) (141,174 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

REDJUVENATE MEDICAL LTD (REGISTERED NUMBER: 12888072)

Balance Sheet - continued
30 September 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 May 2024 and were signed on its behalf by:




Dr A D Greenland - Director



Dr Q Xu - Director


REDJUVENATE MEDICAL LTD (REGISTERED NUMBER: 12888072)

Notes to the Financial Statements
for the Year Ended 30 September 2023

1. STATUTORY INFORMATION

Redjuvenate Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - Straight line over 3 years
Plant and machinery - 20% on cost
Fixtures and fittings - Straight line over 3 years
Computer equipment - Straight line over 3 years

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

REDJUVENATE MEDICAL LTD (REGISTERED NUMBER: 12888072)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2023

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 October 2022
and 30 September 2023 1,648 133,200 1,209 550 136,607
DEPRECIATION
At 1 October 2022 1,098 53,280 806 368 55,552
Charge for year 550 26,640 403 182 27,775
At 30 September 2023 1,648 79,920 1,209 550 83,327
NET BOOK VALUE
At 30 September 2023 - 53,280 - - 53,280
At 30 September 2022 550 79,920 403 182 81,055

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.23 30.9.22
£    £   
Trade debtors 265 -
Other debtors 120 110
385 110

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.23 30.9.22
£    £   
Hire purchase contracts 34,338 33,525
Trade creditors 2,603 981
Other creditors 190,647 141,887
227,588 176,393

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.9.23 30.9.22
£    £   
Hire purchase contracts - 34,338
Other creditors 15,400 -
15,400 34,338

REDJUVENATE MEDICAL LTD (REGISTERED NUMBER: 12888072)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2023

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.23 30.9.22
value: £    £   
100 Ordinary 1 100 100

9. RELATED PARTY DISCLOSURES

QX Medical Limited

A company in which Dr Q Xu is a shareholder and director.


Loans to the value of £15,400 were provided throughout the year. Services to the value of £750 were provided throughout the year.

30.9.23 30.9.22
£    £   
Amount due to related party at the balance sheet date 15,400 -

10. GOING CONCERN

The Directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis in preparing the annual financial statements.